Medafor, Inc. - MPatcH(R) Vascular Closure Device

Medafor, Inc. a US-based medical device company, has introduced its MPatcH(R) Vascular Closure Device, an innovative topical vascular closure system indicated for patients undergoing diagnostic and interventional cardiologic procedures.

The patch system employs Medafor's patented Microporous Polysaccharide Hemospheres (MPH(R)) technology which instantly dehydrates blood at the wound site, creating rapid hemostasis and resilient clotting. This action significantly reduces the necessary time for hemostasis versus manual compression in vascular access procedures.

According to the company the MPatch(R) is the only topically applied closure device utilising Medafor's MPH(R) technology, a patented, plant-based haemostat.

Medafor, Inc., announced that the MPatcH(R) vascular closure system will be available to markets in Europe, Africa, the Middle East, Central and South America and Asia-Pacific. MPatcH(R) will be marketed through Medafor's subsidiaries in Germany and France and its international distributor network. MPatcH(R) is distributed in the U.S. by Possis Medical, Inc.